Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21


Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials.

Thomas Manapurathe D, Krishna SM, Dewdney B, Moxon JV, Biros E, Golledge J.

PLoS One. 2017 Jun 2;12(6):e0178713. doi: 10.1371/journal.pone.0178713. eCollection 2017.


Impact of betablockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease: The COPART Registry.

Mirault T, Galloula A, Cambou JP, Lacroix P, Aboyans V, Boulon C, Constans J, Bura-Riviere A, Messas E.

Medicine (Baltimore). 2017 Feb;96(5):e5916. doi: 10.1097/MD.0000000000005916.


2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations.

Shin J, Park JB, Kim KI, Kim JH, Yang DH, Pyun WB, Kim YG, Kim GH, Chae SC; Guideline Committee of the Korean Society of Hypertension.

Clin Hypertens. 2015 Apr 15;21:3. doi: 10.1186/s40885-014-0014-1. eCollection 2015.


Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?

Poredos P, Jezovnik MK.

Int J Mol Sci. 2015 Jun 25;16(7):14477-89. doi: 10.3390/ijms160714477. Review.


Hydrogen Sulfide Levels and Nuclear Factor-Erythroid 2-Related Factor 2 (NRF2) Activity Are Attenuated in the Setting of Critical Limb Ischemia (CLI).

Islam KN, Polhemus DJ, Donnarumma E, Brewster LP, Lefer DJ.

J Am Heart Assoc. 2015 May 14;4(5). pii: e001986. doi: 10.1161/JAHA.115.001986.


Limb salvage in women.

Huynh TT, Choi L.

Methodist Debakey Cardiovasc J. 2013 Apr;9(2):84-9. Review.


Critical limb ischemia: advanced medical therapy.

Davies MG.

Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):3-9. Review.


Peripheral arterial disease of the lower extremities.

Aronow WS.

Arch Med Sci. 2012 May 9;8(2):375-88. doi: 10.5114/aoms.2012.28568.


Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.

Dhaliwal G, Mukherjee D.

Int J Angiol. 2007 Summer;16(2):36-44.


Optimal management of peripheral arterial disease for the non-specialist.

O'Donnell ME, Reid JA, Lau LL, Hannon RJ, Lee B.

Ulster Med J. 2011 Jan;80(1):33-41. Review.


Secondary Pharmacotherapeutic Prevention among German Primary Care Patients with Peripheral Arterial Disease.

Müller-Bühl U, Laux G, Szecsenyi J.

Int J Vasc Med. 2011;2011:316496. doi: 10.1155/2011/316496. Epub 2011 Jun 26.


ACE up the sleeve - are vascular patients medically optimized?

Coveney AP, O'Brien GC, Fulton GJ.

Vasc Health Risk Manag. 2011 Jan 7;7:15-21. doi: 10.2147/VHRM.S15484.


Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review.

Kasapis C, Gurm HS.

Curr Cardiol Rev. 2009 Nov;5(4):296-311. doi: 10.2174/157340309789317823.


Peripheral artery disease: current insight into the disease and its diagnosis and management.

Olin JW, Sealove BA.

Mayo Clin Proc. 2010 Jul;85(7):678-92. doi: 10.4065/mcp.2010.0133.


Management of lower extremity peripheral arterial disease.

Gardner AW, Afaq A.

J Cardiopulm Rehabil Prev. 2008 Nov-Dec;28(6):349-57. doi: 10.1097/HCR.0b013e31818c3b96. Review.


Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.

Albouaini K, Andron M, Alahmar A, Egred M.

Int J Chron Obstruct Pulmon Dis. 2007;2(4):535-40. Review.


Peripheral arterial disease in the elderly.

Aronow WS.

Clin Interv Aging. 2007;2(4):645-54. Review.


Do beta-blockers have a role in treating hypertension? Yes.

Khan N, McAlister FA.

Can Fam Physician. 2007 Apr;53(4):614-21. Review. English, French. No abstract available.


Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly.

Reeves RA, Fodor JG, Gryfe CI, Patterson C, Spence JD.

CMAJ. 1993 Sep 15;149(6):815-20. Review.

Supplemental Content

Support Center